Table 2 –

Multivariable Linear Regression Models for Percentage of Time Up to Date with HCC Surveillance

	Model 1		Model 2
	Coefficient (95% CI)	p-value	Coefficient (95% CI)	p-value
GI/Hep Telemed *	2.23 (1.95 – 2.51)	<0.001	2.13 (1.85 – 2.41)	<0.001
GI/Hep In-person *	3.29 (2.94 – 3.65)	<0.001	3.22 (2.87 – 3.57)	<0.001
PCP Telemed *	0.27 (−0.03 – 0.58)	0.08	0.22 (−0.09 – 0.52)	0.17
PCP In-person *	−0.15 (−0.37 – 0.06)	0.16	−0.11 (−0.33 – 0.10)	0.29
Age (per year)			0.05 (−0.01 – 0.10)	0.11
Race/Ethnicity
White			(ref)
Black			0.99 (−0.08 – 2.07)	0.07
Hispanic			0.60 (−0.96 – 2.16)	0.45
Asian			6.22 (2.63 – 9.80)	0.001
Other			−3.10 (−4.75 – −1.45)	<0.001
Diabetes			3.12 (2.24 – 4.00)	<0.001
Coronary Artery Disease			−1.04 (−2.00 – −0.09)	0.03
Etiology
Hepatitis C virus (HCV)			(ref)
Hepatitis B virus			9.37 (5.72 – 13.01)	<0.001
Alcohol-related liver disease (ALD)			−6.18 (−7.35 – −5.02)	<0.001
HCV+ALD			−3.33 (−4.57 – −2.10)	<0.001
Non-alcoholic fatty liver disease			−5.67 (−6.90 – −4.43)	<0.001
Other			−7.96 (−10.32 – −5.60)	<0.001
MELD-Na			−0.33 (−0.44 – −0.23)	<0.001
CTP Class
A			(ref)
B			6.68 (4.94 – 8.41)	<0.001
Academic Center			4.86 (3.99 – 5.74)	<0.001
Center Advanced Liver Disease Dashboard Usage
Not Using			(ref)
Intermittent Use			5.66 (3.83 – 7.48)	<0.001
Routine Use			8.51 (6.86 – 10.17)	<0.001

^*Per appointment per 6 months